Pilot Study Using an NMDA Antagonist to Modulate Transcranial Direct Current Stimulation (tDCS) Effects on Sensory Discrimination

NCT02426983 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia

Interventions

DEVICE: Direct Current Stimulation
DRUG: Dextromethorphan

Sponsor

University of Ottawa